Ignite Creation Date:
2024-05-06 @ 7:27 AM
Last Modification Date:
2024-10-26 @ 11:48 AM
Study NCT ID:
NCT02535000
Status:
COMPLETED
Last Update Posted:
2020-10-09
First Post:
2015-08-23
Brief Title:
Duloxetine as an Analgesic Agent in Patients Undergoing Elective Spine Surgery
Sponsor:
Serviço de Anestesiologia de Joinville
Organization:
Serviço de Anestesiologia de Joinville
Study Overview
Official Title:
Duloxetine as an Analgesic Agent in Patients Undergoing Elective Spine Surgery
Status:
COMPLETED
Status Verified Date:
2020-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Duloxetine
Brief Summary:
Duloxetine as an analgesic agent in patients undergoing elective spine surgery evaluation with fentanyl demand controlled by the patient The primary objective is to evaluate the efficacy of duloxetine in fentanyl consumption during the postoperative period of patients undergoing elective spine surgery by intervertebral disc degeneration Secondary endpoints were pain scores and the presence or absence of adverse effects such as headache nausea vomiting itching dizziness and drowsiness
Detailed Description:
Multimodal analgesia is widely advocated for the control of perioperative pain in an attempt to reduce the use of opioids and their side effects Duloxetine is a selective inhibitor of serotonin and norepinephrine reuptake with demonstrated efficacy in chronic pain such as painful diabetic neuropathy and postherpetic neuralgia The primary objective is to evaluate the efficacy of duloxetine in fentanyl consumption during the postoperative period of patients undergoing elective spine surgery by intervertebral disc degeneration Duloxetine as an analgesic agent in patients undergoing elective spine surgery evaluation with fentanyl demand controlled by the patient The primary objective is to evaluate the efficacy of duloxetine in fentanyl consumption during the postoperative period of patients undergoing elective spine surgery by degenerative disc disease Secondary endpoints were pain scores and the presence or absence of adverse effects such as headache nausea vomiting itching dizziness and drowsiness
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None